Hasegawa T, Oyama N, Kasamatsu H, Chino T, et al. Intertriginous erythema associated with enfortumab vedotin, a nectin-4-targeting antibody-drug conjugate, in a case with metastatic urothelial cancer: Immunohistochemical evidence for molecular-targeted eruption. J Dermatol 2022;49:e453-e454.
PMID: 36052729